Pharmacology News

Prescription drug prices in the United States are an average of 2.56 times higher than those seen in 32 other nations, according to a RAND Corporation report.

Undeterred by the FDA’s rejection of filgotinib over testicular toxicity concerns, the United Kingdom’s National Institute for Health and Clinical Excellence has endorsed its use among eligible patients on England’s National Health Service.

Women with previous pregnancy losses who adhered to a low-dose aspirin regimen while trying to conceive had better outcomes than women who received placebo, results from a per protocol analysis of a randomized trial showed.

The FDA has expanded the approval of a remote electrical neuromodulation device to treat episodic and chronic migraine in children aged 12 years and older, according to a press release issued by the manufacturer.

HHS has released new guidance that the agency said will improve access to medication-assisted treatment for opioid use disorder.

High pollen levels may cause flare-ups in urologic chronic pelvic pain syndrome, according to research published in The Journal of Urology.

Although clinical visits and refills among patients already receiving opioid use disorder medication did not decrease during the early months of the COVID-19 pandemic, fewer people initiated new treatment, according to research published in JAMA Network Open.

On Monday, the FDA issued a statement reminding the public of the importance of following COVID-19 vaccine dosing schedules currently authorized by the agency.

Healio Primary Care is pleased to announce the creation of its Peer Perspective Board — a group of dedicated experts who will help guide our efforts to provide the latest news and updates that impact daily practice.

Breaking news and emerging research on the COVID-19 pandemic dominated headlines this year. However, there were other important updates that impact practice.